SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
01-Mar-24 8:20 PM View: | Krystal Biotech, Inc. (KRYS) | 28-Feb-24 | Payment of Exercise | 2,314 | $163.08 | $377,367.00 | (10%) 22.94K to 20.62K | |
01-Mar-24 8:16 PM View: | Krystal Biotech, Inc. (KRYS) | 28-Feb-24 | Option Exercise | 7,500 | $63.55 | $476,625.00 | 58% 12.94K to 20.44K | < 1% |
01-Mar-24 8:20 PM View: | Krystal Biotech, Inc. (KRYS) | 28-Feb-24 | Option Exercise | 5,000 | -- | -- | 39% 12.94K to 17.94K | |
01-Mar-24 8:20 PM View: | Krystal Biotech, Inc. (KRYS) | 28-Feb-24 | Option Exercise | 5,000 | $63.55 | $317,750.00 | 28% 17.94K to 22.94K | |
01-Mar-24 8:16 PM View: | Krystal Biotech, Inc. (KRYS) | 28-Feb-24 | Planned Private Option Sale | 7,500 | $166.05 | $1,245,380.00 | (37%) 20.44K to 12.94K | |
01-Mar-24 8:20 PM View: | Krystal Biotech, Inc. (KRYS) | 28-Feb-24 | Planned Option Sale | 5,000 | $165.88 | $829,417.00 | (24%) 20.62K to 15.62K | |
28-Feb-24 9:33 PM View: | Krystal Biotech, Inc. (KRYS) | 27-Feb-24 | Option Exercise | 1,913 | $52.26 | $99,973.40 | 17% 11.02K to 12.94K | |
28-Feb-24 9:33 PM View: | Krystal Biotech, Inc. (KRYS) | 26-Feb-24 | Payment of Exercise | 1,533 | $157.00 | $240,681.00 | (7%) 20.64K to 19.11K | |
28-Feb-24 9:33 PM View: | Krystal Biotech, Inc. (KRYS) | 26-Feb-24 | Option Exercise | 8,087 | $52.26 | $422,627.00 | 64% 12.56K to 20.64K | |
28-Feb-24 9:33 PM View: | Krystal Biotech, Inc. (KRYS) | 26-Feb-24 | Planned Option Sale | 8,087 | $136.91 | $1,107,180.00 | (42%) 19.11K to 11.02K | |
24-Jan-24 5:44 PM View: | Krystal Biotech, Inc. (KRYS) | 22-Jan-24 | Option Exercise | 2,500 | $52.26 | $130,650.00 | 20% 12.56K to 15.06K | |
24-Jan-24 5:44 PM View: | Krystal Biotech, Inc. (KRYS) | 22-Jan-24 | Planned Option Sale | 2,500 | $130.00 | $325,000.00 | (17%) 15.06K to 12.56K | |
23-May-23 4:23 PM View: | Krystal Biotech, Inc. (KRYS) | 22-May-23 | Option Exercise | 25,000 | $57.90 | $1,447,620.00 | 199% 12.56K to 37.56K | |
23-May-23 4:23 PM View: | Krystal Biotech, Inc. (KRYS) | 22-May-23 | Planned Option Sale | 22,479 | $109.04 | $2,451,100.00 | (60%) 37.56K to 15.08K | |
23-May-23 4:23 PM View: | Krystal Biotech, Inc. (KRYS) | 22-May-23 | Sale (Planned) | 2,521 | $109.04 | $274,889.00 | (17%) 15.08K to 12.56K | |
23-May-23 4:23 PM View: | Krystal Biotech, Inc. (KRYS) | 19-May-23 | Option Exercise | 25,000 | $52.26 | $1,306,500.00 | 156% 15.98K to 40.98K | |
23-May-23 4:23 PM View: | Krystal Biotech, Inc. (KRYS) | 19-May-23 | Planned Option Sale | 27,521 | $95.05 | $2,615,910.00 | (67%) 40.98K to 13.46K | |
23-May-23 4:23 PM View: | Krystal Biotech, Inc. (KRYS) | 19-May-23 | Sale (Planned) | 907 | $95.05 | $86,211.70 | (7%) 13.46K to 12.56K | |
28-Feb-23 10:00 PM View: | Krystal Biotech, Inc. (KRYS) | 26-Feb-23 | Payment of Exercise | 2,144 | $78.46 | $168,218.00 | (12%) 18.13K to 15.98K | |
01-Mar-22 9:25 PM View: | Krystal Biotech, Inc. (KRYS) | 26-Feb-22 | Payment of Exercise | 1,472 | $62.50 | $92,000.00 | (8%) 19.6K to 18.13K | (2%) |
02-Mar-21 8:40 PM View: | Krystal Biotech, Inc. (KRYS) | 26-Feb-21 | Grant | 19,600 | -- | -- | 100% 0 to 19.6K |